These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1531403

  • 1. Erythematous, hemorrhagic, and necrotic plaques in an elderly man. Coumarin-induced skin necrosis.
    Sharafuddin MJ, Sanaknaki BA, Kibbi AG.
    Arch Dermatol; 1992 Jan; 128(1):105, 108. PubMed ID: 1531403
    [No Abstract] [Full Text] [Related]

  • 2. [Sintrom-induced cutaneous necrosis; a little-known complication].
    Núñez L, Córcoles JL, Romero A, Guedes P, Amorós C, Morillas P.
    Arch Cardiol Mex; 2018 Jan; 88(1):76-77. PubMed ID: 28864238
    [No Abstract] [Full Text] [Related]

  • 3. Leukocytoclastic vasculitis: another coumarin-induced hemorrhagic reaction.
    Tamir A, Wolf R, Brenner S.
    Acta Derm Venereol; 1994 Mar; 74(2):138-9. PubMed ID: 7911622
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cutaneous necrosis and multinucleate epidermal cells associated with intravenous phenytoin.
    Hunt SJ.
    Am J Dermatopathol; 1995 Aug; 17(4):399-402. PubMed ID: 8600807
    [Abstract] [Full Text] [Related]

  • 6. Case of cetuximab-induced disseminated necrotic and maculopapular eruptions: Involvement of an epidermal growth factor receptor inhibitor with epidermal necrosis.
    Namiki T, Omigawa C, Nojima K, Wakasa T, Tokoro S, Hanafusa T, Miura K, Yokozeki H.
    J Dermatol; 2018 Jan; 45(1):e3-e4. PubMed ID: 28971521
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Erythematous-to-brownish plaques on the upper back: a quiz. Phenytoin-induced T-cell predominant pseudolymphoma (“pseudomycosis fungoides”) with T-cell clonality.
    Toberer F, Hartschuh W, Kutzner H, Flux K.
    Acta Derm Venereol; 2015 Mar; 95(3):378-82. PubMed ID: 25111894
    [No Abstract] [Full Text] [Related]

  • 10. BRAF Inhibitor-Induced Antitumoral Granulomatous Dermatitis Eruption in Advanced Melanoma.
    Garrido MC, Gutierrez C, Riveiro-Falkenbach E, Ortiz P, Rodriguez-Peralto JL.
    Am J Dermatopathol; 2015 Oct; 37(10):795-8. PubMed ID: 26381028
    [Abstract] [Full Text] [Related]

  • 11. Non-pigmenting fixed drug eruption induced by sorafenib.
    Tanabe K, Amoh Y, Mii S, Eto H, Iwamura M, Katsuoka K.
    Acta Derm Venereol; 2010 May; 90(3):307. PubMed ID: 20526556
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fixed drug eruption (phenolphthalein). Evidence for a blood-borne mediator.
    Wyatt E, Greaves M, Sondergaard J.
    Arch Dermatol; 1972 Nov; 106(5):671-3. PubMed ID: 4117910
    [No Abstract] [Full Text] [Related]

  • 14. Persistent supravenous erythematous eruption: a rare local complication of intravenous 5-fluorouracil therapy.
    Pujol RM, Rocamora V, Lopez-Pousa A, Taberner R, Alomar A.
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):839-42. PubMed ID: 9810911
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Etizolam-induced superficial erythema annulare centrifugum.
    Kuroda K, Yabunami H, Hisanaga Y.
    Clin Exp Dermatol; 2002 Jan; 27(1):34-6. PubMed ID: 11952667
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: a relevant class-effect.
    Garcovich S, Burlando M, Rongioletti F, Garcovich A, Parodi A, Amerio P.
    Acta Derm Venereol; 2010 May; 90(3):311-2. PubMed ID: 20526559
    [No Abstract] [Full Text] [Related]

  • 19. [Secondary drug toxiderma to acenocoumarol].
    Khammassi N, Kessentini N.
    Pan Afr Med J; 2015 May; 22():95. PubMed ID: 26848342
    [No Abstract] [Full Text] [Related]

  • 20. Is cetuximab-induced rash conclusion really a remnant of the skin erythema dose?
    Oskan F, Belka C, Manapov F.
    Int J Radiat Oncol Biol Phys; 2013 Nov 01; 87(3):462-3. PubMed ID: 24074919
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.